ES537268A0 - Un procedimiento para la preparacion de compuestos de 1,4-dihidropiridina. - Google Patents

Un procedimiento para la preparacion de compuestos de 1,4-dihidropiridina.

Info

Publication number
ES537268A0
ES537268A0 ES537268A ES537268A ES537268A0 ES 537268 A0 ES537268 A0 ES 537268A0 ES 537268 A ES537268 A ES 537268A ES 537268 A ES537268 A ES 537268A ES 537268 A0 ES537268 A0 ES 537268A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
dihydropyridine compounds
dihydropyridine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES537268A
Other languages
English (en)
Other versions
ES8507111A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES537268A0 publication Critical patent/ES537268A0/es
Publication of ES8507111A1 publication Critical patent/ES8507111A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ES537268A 1983-03-10 1984-10-31 Un procedimiento para la preparacion de compuestos de 1,4-dihidropiridina. Expired ES8507111A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838306666A GB8306666D0 (en) 1983-03-10 1983-03-10 Therapeutic agents

Publications (2)

Publication Number Publication Date
ES537268A0 true ES537268A0 (es) 1985-08-16
ES8507111A1 ES8507111A1 (es) 1985-08-16

Family

ID=10539350

Family Applications (3)

Application Number Title Priority Date Filing Date
ES530379A Expired ES8506275A1 (es) 1983-03-10 1984-03-08 Un procedimiento para la preparacion de compuestos de 1, 4-dihidropiridina.
ES537268A Expired ES8507111A1 (es) 1983-03-10 1984-10-31 Un procedimiento para la preparacion de compuestos de 1,4-dihidropiridina.
ES537269A Expired ES8507112A1 (es) 1983-03-10 1984-10-31 Un procedimiento para la prpeparacion de compuestos de 1,4-dihidropiridina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES530379A Expired ES8506275A1 (es) 1983-03-10 1984-03-08 Un procedimiento para la preparacion de compuestos de 1, 4-dihidropiridina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES537269A Expired ES8507112A1 (es) 1983-03-10 1984-10-31 Un procedimiento para la prpeparacion de compuestos de 1,4-dihidropiridina.

Country Status (17)

Country Link
US (1) US4590195A (es)
EP (1) EP0119050B1 (es)
JP (1) JPS59175466A (es)
KR (1) KR840008147A (es)
AU (1) AU546634B2 (es)
DE (1) DE3477379D1 (es)
DK (1) DK168378B1 (es)
ES (3) ES8506275A1 (es)
FI (1) FI840955A7 (es)
GB (1) GB8306666D0 (es)
GR (1) GR81872B (es)
HU (1) HU191220B (es)
IE (1) IE57116B1 (es)
IL (1) IL71187A0 (es)
PH (1) PH20692A (es)
PL (2) PL252773A1 (es)
PT (1) PT78219B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421039D0 (en) * 1984-08-17 1984-09-19 Wyeth John & Brother Ltd Heterocyclic compounds
GB8501395D0 (en) * 1985-01-19 1985-02-20 Pfizer Ltd Dihydropyridine anti-ischaemic & anti-hypertensive agents
IT1204421B (it) * 1986-06-27 1989-03-01 Boehringer Biochemia Srl 2-(aminoalchiltio)metil-1,4-diidropiridine,un metodo per la loro preparazione e composizioni farmaceutiche che le contengono
EP0233228A1 (en) * 1985-08-06 1987-08-26 Boehringer Mannheim Italia S.P.A. Pharmaceutically active 2-thiomethyl-substituted-1,4-dihydropyridines
IT1201454B (it) * 1985-08-19 1989-02-02 Boehringer Biochemia Srl 1,4-diidropiridine-2-sostituite
GB8527698D0 (en) * 1985-11-09 1985-12-11 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents
EP0225175A3 (en) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof
DE3621104A1 (de) * 1986-06-24 1988-01-07 Heumann Pharma Gmbh & Co 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
IT1197012B (it) * 1986-07-29 1988-11-25 Boehringer Biochemia Srl 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono
FR2602231B1 (fr) * 1986-08-04 1988-10-28 Adir Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
IT1213555B (it) * 1986-12-11 1989-12-20 Boehringer Biochemia Srl 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.
IT1215381B (it) * 1987-03-12 1990-02-08 Boehringer Biochemia Srl Farmaceutiche che le contengono. carbonil- e solfonil- derivati di 2-(aminoalchiltio)metil-1,4-diidropiridine, un metodo per la loro preparazione e composizioni
GB8710493D0 (en) * 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
US5278169A (en) * 1988-08-09 1994-01-11 E. R. Squibb & Sons, Inc. Method of treating or prevention of fibrillation of the heart
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
IE960441L (en) * 1988-12-27 1990-06-27 Takeda Chemical Industries Ltd Guanidine derivatives, their production and insecticides
AT5874U1 (de) 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
AU2003225370A1 (en) * 2002-04-13 2003-11-03 Hanlim Pharmaceutical Co., Ltd. Amlodipine nicotinate and process for the preparation thereof
EP1554267A1 (en) * 2002-10-07 2005-07-20 Artesian Therapeutics, Inc. Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity
US20070066619A1 (en) * 2002-10-07 2007-03-22 Artesian Therapeutics, Inc. Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3974278A (en) * 1973-07-12 1976-08-10 Bayer Aktiengesellschaft 1,4-Dihydropyridine esters
US4177278A (en) * 1977-04-05 1979-12-04 Bayer Aktiengesellschaft 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use
JPS5547656A (en) * 1978-09-29 1980-04-04 Dainippon Pharmaceut Co Ltd 2-(2-substituted aminoethyl)-1,4-dihydropyridine derivative and its derivative
SE7910521L (sv) * 1979-12-20 1981-06-21 Haessle Ab Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
US4568677A (en) * 1983-07-23 1986-02-04 Pfizer Inc. 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents

Also Published As

Publication number Publication date
EP0119050A3 (en) 1987-07-01
HU191220B (en) 1987-01-28
KR840008147A (ko) 1984-12-13
GR81872B (es) 1984-12-12
DK135884D0 (da) 1984-02-29
PT78219B (en) 1986-08-12
EP0119050A2 (en) 1984-09-19
IE57116B1 (en) 1992-05-06
DK135884A (da) 1984-09-11
FI840955A7 (fi) 1984-09-11
DK168378B1 (da) 1994-03-21
ES537269A0 (es) 1985-08-16
PH20692A (en) 1987-03-24
ES530379A0 (es) 1985-07-01
IL71187A0 (en) 1984-06-29
EP0119050B1 (en) 1989-03-22
ES8506275A1 (es) 1985-07-01
IE840585L (en) 1984-09-10
JPS59175466A (ja) 1984-10-04
PL246574A1 (en) 1985-08-13
PT78219A (en) 1984-04-01
AU546634B2 (en) 1985-09-12
ES8507111A1 (es) 1985-08-16
DE3477379D1 (en) 1989-04-27
AU2546484A (en) 1984-09-13
GB8306666D0 (en) 1983-04-13
PL252773A1 (en) 1985-11-19
US4590195A (en) 1986-05-20
FI840955A0 (fi) 1984-03-08
ES8507112A1 (es) 1985-08-16

Similar Documents

Publication Publication Date Title
ES538256A0 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
ES510449A0 (es) Un procedimiento para la preparacion de 1,2,4-triazolonas.fenoxial-quilicas.
ES533753A0 (es) Un procedimiento para la preparacion de nuevas fenoxialquil-1-2-4-triazolonas.
ES545756A0 (es) Un procedimiento para la preparacion de un derivado de acido6-fluor-1,4-dihidro-4-oxo-7-piperazinilquinolin sustituido-3-carboxilico
ES542703A0 (es) Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos.
ES537269A0 (es) Un procedimiento para la prpeparacion de compuestos de 1,4-dihidropiridina.
ES520195A0 (es) Procedimiento para preparar nuevos derivados de 3-ceto- 4,9,19-nor-esteroides.
ES536286A0 (es) Un procedimiento para la preparacion de compuestos de 1,4,4-triazolona.
ES542120A0 (es) Un procedimiento para la preparacion de 1,4-dihidropiridinas.
ES530418A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES534607A0 (es) Un procedimiento para la preparacion de un derivado de poliol-eter.
ES510354A0 (es) Un procedimiento para la preparacion de 2,3-dicloro-5-triclorometilpiridina.
ES531792A0 (es) Un procedimiento para la preparacion de un compuesto.
ES539543A0 (es) Un procedimiento para la preparacion de nuevos compuestos de oxadiazinona.
ES501432A0 (es) Un procedimiento para la preparacion de 4,5-diaril-&-cpolifluoralquil)-1-4-pirrol-2metanaminas antiinflamatorias.
ES501077A0 (es) Un procedimiento para la preparacion de 4-alquil-sustituido-3--hidroxi-3-pirrolin-2,5 dionas.
ES543997A0 (es) Un procedimiento para la preparacion de derivados de 1,4-dihidropiridina.
ES532689A0 (es) Un procedimiento para la preparacion de un derivado de 2, 4-dihidro-5-(fenil (substituido))-3h-pirazol-3-ona
ES539592A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,4-dihidropiridina.
ES531760A0 (es) Un metodo para la preparacion de 1,8-dihidroxi-10-acil-9-antronas.
ES535551A0 (es) Un procedimiento para la preparacion de nuevos 16-fluor-16,17-dideshidro prostanoides.
ES528225A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,2,5,-tidiazol.
ES535966A0 (es) Un procedimiento para la preparacion de nuevos derivados de 4,5-dihidro-2h-piridazin-3-ona.
ES522573A0 (es) Un procedimiento para la preparacion de dihidropiridinas.
ES528986A0 (es) Un procedimiento para la preparacion de un compuesto de beta-lactama.